Related Experiment Video

Updated: Aug 17, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Screening for metabolic disorders. How are we doing?

M Irons1

  • 1Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts.

Pediatric Clinics of North America
|October 1, 1993
PubMed

Insights

Pediatric screening for phenylketonuria and congenital hypothyroidism is standard practice. New data offers improved care strategies for these and other metabolic disorders in children.

Area of Science:

  • Pediatric Medicine
  • Metabolic Disorders
  • Newborn Screening

Background:

  • Routine newborn screening is essential in pediatric practice.
  • Screening for phenylketonuria and congenital hypothyroidism is well-established.
  • Several other metabolic disorder screenings are in use for decades.

Purpose of the Study:

  • To provide pediatricians with updated information.
  • To improve the care of children with metabolic disorders.
  • To support ongoing pediatric screening practices.

Main Methods:

  • Review of current screening protocols.
  • Analysis of new data on metabolic disorders.
  • Synthesis of information for clinical application.

Main Results:

  • Updated information is available for pediatricians.
  • Enhanced care strategies can be developed.
  • Improved outcomes for children with screened disorders are anticipated.

Conclusions:

  • New information aids pediatricians in managing metabolic disorders.
  • Continued advancements in screening benefit child health.
  • The integration of new data supports evolving pediatric care standards.

More Related Videos

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides08:39

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...